← Organogenesis Holdings Inc.

	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent	($209k)	($2.1m)	($64.8m)	($40.5m)	$17.9m	$94.9m	$15.5m	$4.9m	$861k	$37.0m
Net Income (Loss) Available to Common Stockholders, Basic	($14.8m)	($4.4m)	($64.8m)	($41.1m)	$17.9m	$94.9m	$15.5m	$4.9m	($937k)	$20.0m
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	—	—	($64.8m)	($40.5m)	$17.9m	$94.9m	$15.5m	$4.9m	$861k	$37.0m
Depreciation, Depletion and Amortization	$5.7m	$3.6m	$3.3m	$3.4m	$3.7m	$5.8m	$5.8m	$10.4m	$13.6m	$15.3m
Amortization of Intangible Assets	$1.6m	$2.0m	$3.7m	$6.0m	$3.7m	$4.9m	$4.9m	$4.9m	$3.4m	$3.3m
Deferred Income Tax Expense (Benefit)	—	($7.3m)	$186k	$111k	$112k	($32.0m)	$2.0m	$2.0m	($10.7m)	$9.5m
Share-based Payment Arrangement, Noncash Expense	—	—	$1.1m	$936k	$1.7m	$3.9m	$6.6m	$9.0m	$10.6m	$13.3m
Payment, Tax Withholding, Share-based Payment Arrangement	—	—	—	—	—	$737k	$648k	$332k	$1.2m	$1.9m
Goodwill, Impairment Loss	—	—	—	—	—	$0	$0	$0	$0	$0
Gain (Loss) on Disposition of Property Plant Equipment	($9k)	($8k)	($1.2m)	($146k)	($201k)	($1.4m)	($4.5m)	($235k)	($1.1m)	($188k)
Gain (Loss) on Extinguishment of Debt	—	—	($2.1m)	($1.9m)	—	($1.9m)	—	—	($215k)	—
Income Tax Expense (Benefit)	—	($7.3m)	$84k	$150k	$530k	($31.1m)	$4.8m	$5.4m	($3.7m)	$9.9m
Interest Expense Nonoperating	—	—	—	—	—	—	—	—	$1.5m	($2.3m)
Operating Lease, Expense	—	—	$2.8m	$6.2m	$6.5m	—	—	—	—	—
Other Nonoperating Income (Expense)	—	—	$162k	$13k	$97k	($13k)	($13k)	$57k	$20k	($5k)
Changes in operating assets and liabilities:
Additional Financial Items
Increase (Decrease) in Accounts Receivable	—	—	$7.1m	$4.7m	$18.8m	$28.7m	$8.8m	($5.5m)	$31.8m	$115.8m
Increase (Decrease) in Inventories	—	—	$5.0m	$11.1m	$6.7m	$9.3m	$9.4m	$8.2m	$6.2m	$17.9m
Increase (Decrease) in Accounts Payable	—	—	($60k)	$4.7m	($635k)	$3.8m	$3.3m	($108k)	($2.4m)	($528k)
Proceeds from Stock Options Exercised	—	$221k	$119k	$269k	$2.8m	$2.2m	$2.1m	$0	$1.2m	$157k
Accretion Expense	—	—	$0	—	—	—	—	—	—	—
Gain (Loss) on Termination of Lease	—	—	—	—	—	—	$0	($559k)	$0	—
Gain (Loss) Related to Litigation Settlement	—	—	—	—	$2.2m	—	—	—	—	—
Goodwill	—	—	$25.5m	$25.5m	$28.8m	$28.8m	$28.8m	$28.8m	$28.8m	$28.8m
Investment Income, Interest	—	$2.5m	$64k	—	—	—	—	—	—	—
Nonoperating Income (Expense)	—	—	($13.2m)	($10.8m)	($8.9m)	($9.1m)	($2.0m)	($2.1m)	($1.5m)	$2.3m
Operating Costs and Expenses	—	—	—	—	—	—	—	—	—	$137.5m
Operating Expenses	$209k	$4.6m	$176.2m	$214.5m	$223.6m	$280.9m	$323.6m	$314.1m	$367.6m	$519.5m
Net Cash Provided by (Used in) Operating Activities	($562k)	($587k)	($60.7m)	($33.5m)	$6.8m	$62.0m	$24.9m	$30.9m	$14.2m	($10.3m)
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment	$1.4m	$2.4m	$1.9m	$6.0m	$21.1m	$31.2m	$33.9m	$24.4m	$10.0m	$14.2m
Net Cash Provided by (Used in) Investing Activities	($310.0m)	($14.9m)	($1.9m)	($6.2m)	($24.8m)	($31.2m)	($33.9m)	($24.4m)	($10.0m)	($14.2m)
Cash flows from financing activities:
Proceeds from Issuance of Common Stock	$303.8m	—	—	$50.3m	$64.7m	—	$0	$0	$120.7m	—
Payments for Repurchase of Common Stock	—	—	—	—	—	—	$0	$0	$25.5m	—
Net Cash Provided by (Used in) Financing Activities	$311.5m	($328k)	$81.6m	$78.7m	$42.5m	($1.0m)	($2.2m)	($5.5m)	$27.6m	($17.4m)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$659k	$500k	$19.0m	$39.0m	$24.4m	$29.7m	($11.2m)	$1.0m	$31.8m	($41.8m)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$659k	$500k	$21.4m	$60.4m	$84.8m	$114.5m	$103.3m	$104.3m	$136.2m	$94.3m
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities	$4.0m	$5.7m	$7.6m	$8.1m	$9.6m	$5.8m	$2.6m	$5.4m	$5.0m	—
Income Taxes Paid, Net	$29k	$96k	$8k	$49k	$61k	$607k	$1.2m	$3.1m	$7.0m	$5.3m